A multicenter real-world analysis of first-line systemic monotherapy for locally advanced basal cell carcinoma

JAAD Case Rep. 2023 Oct 29:42:69-71. doi: 10.1016/j.jdcr.2023.10.006. eCollection 2023 Dec.

¹ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
² Department of Dermatology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
³ Department of Radiation Oncology, Perelman Center for Advanced Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
⁴ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
⁵ Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁶ Department of Radiation Oncology, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.

No abstract available

Keywords: basal cell carcinoma; competing-risk analysis; hedgehog inhibitors; immunotherapy; systemic therapy; treatment outcomes.

Publication types